RecruitingNot ApplicableNCT05338294

The Effect of Laparoscopic Splenectomy and Azygoportal Disconnection on the Immune Function for Cirrhosis Patients

Sponsor

Northern Jiangsu People's Hospital

Enrollment

20 participants

Start Date

Mar 1, 2022

Study Type

INTERVENTIONAL

Conditions

Cirrhosis, Liver Splenectomy; Status

Summary

In this study, the investigators compared the improvement of immune function related indicators in patients with liver cirrhosis after laparoscopic splenectomy and azygoportal disconnection. To determine whether surgical treatment can help enhance postoperative immune function and improve patient prognosis.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Laparoscopic splenectomy and azygoportal disconnection for people with cirrhosis, liver and splenectomy; status. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.